About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Reboxetine for Sleep Apnoea After ENT Surgery | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGPhase 2NCT05978505

Reboxetine for Sleep Apnoea After ENT Surgery

This pilot study will establish the feasibility of a larger trial to investigate whether reboxetine, a medication used to treat depression, can reduce the severity of obstructive sleep apnea (OSA) inc...

Lead sponsor: Flinders University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Emma Thomas

CONTACT

+61882012912 ethomas@flinders.edu.au

Carolin Tran

CONTACT

+61874219873 carolin.tran@flinders.edu.au

Sponsors

Lead Sponsor

Flinders University

Collaborators

Flinders Medical Centre

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age \>18 years
•Undergoing elective upper airway surgery
•History of obstructive sleep apnoea (OSA)

Exclusion Criteria

•Clinically significant cardiac disease (e.g., arrhythmia, coronary artery disease, or cardiac failure)
•History of clinically significant urinary retention, bladder outlet obstruction, or benign prostatic hyperplasia
•Poorly controlled hypertension
•Epilepsy
•History of schizophrenia, schizoaffective disorder or bipolar disorder according to Diagnostic and Statistical Manual of Mental Disorders-V or International Classification of Disease 10th edition criteria
•History of attempted suicide or suicidal ideation within 1 year prior to screening, or current suicidal ideation
•Narrow angle glaucoma

Related studies

RECRUITINGPhase 1

Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine

NCT03860233 · Sleep Apnea, Sleep Apnea, Obstructive

Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal

NCT05939934 · Sleep Apnea, Obstructive, Endothelial Dysfunction

Maxillomandibular Advancement Surgery for Treatment of Obstructive Sleep Apnoea Syndrome

NCT07446634 · Sleep Apnea, Obstructive

Accuracy of the Sensory Test Using the Laryngopharyngeal Endoscopic Esthesiometer in Obstructive Sleep Apnea

NCT03109171 · Sleep Apnea, Obstructive, Larynx, and more

Predicting Outcomes in Hypoglossal Nerve Stimulation Therapy With Stimulated Upper Airway Mechanics

NCT05429983 · Sleep Apnea, Obstructive

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 3, 2024Terms

Trial snapshot

StatusRECRUITING

PhasePHASE2

Enrollment20

Start dateAug 2023

Last updatedOct 3, 2024

Condition

Sleep Apnea, Obstructive

Locations shown

Flinders, Private and Public Hospitals and Flinders University

Bedford Park, South Australia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 3, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions